1461097686-5e504466-bf73-419b-b4ef-b349e4805b14

1. A method for manufacturing a semiconductor structure, which comprises the following steps:
a) providing an SOI substrate, a shallow trench is formed on the SOI substrate, with the defined area of the shallow trench corresponding to the active region;
b) forming a heavily doped layer on a sidewall of the shallow trench close to the active region;
c) filling the shallow trench to form the shallow trench isolation structure;
d) forming the semiconductor device in the active region.
2. The method according to claim 1, in step b), the active region adjacent to the sidewall corresponds to the source region.
3. The method according to claim 2, the sidewall is perpendicular to the direction of the length of the channel in the semiconductor device.
4. The method according to claim 1, in step b), the heavily doped layer is formed by large angle tilt ion implantation.
5. The method according to claim 4, the angle for the large angle tilt ion implantation is 10\xb0 \u02dc45\xb0.
6. The method according to claim 4, wherein, the implantation energy is less than 1 keV, the implantation dose is greater than 5\xd71014 cm-2, and the peak doping is greater than 7\xd71019 cm-3.
7. The method according to claim 1, in step b), before the formation of the heavily doped layer, a masking layer is used to cover the portion of the semiconductor structure corresponding to the drain region of the semiconductor device.
8. The method according to claim 1, in step b), for NMOS devices, the heavily doped layer is p-doped, and the ion implanted is B or BF2; for PMOS devices, the heavily doped layer is n-doped, and the ion implanted is P or As.
9. The method according to claim 2, in step b), for NMOS devices, the heavily doped layer is p-doped, and the ion implanted is B or BF2; for PMOS devices, the heavily doped layer is n-doped, and the ion implanted is P or As.
10. The method according to claim 3 in step b), for NMOS devices, the heavily doped layer is p-doped, and the ion implanted is B or BF2; for PMOS devices, the heavily doped layer is n-doped, and the ion implanted is P or As.
11. The method according to claim 4 in step b), for NMOS devices, the heavily doped layer is p-doped, and the ion implanted is B or BF2; for PMOS devices, the heavily doped layer is n-doped, and the ion implanted is P or As.
12. The method according to claim 5 in step b), for NMOS devices, the heavily doped layer is p-doped, and the ion implanted is B or BF2; for PMOS devices, the heavily doped layer is n-doped, and the ion implanted is P or As.
13. The method according to claim 6 in step b), for NMOS devices, the heavily doped layer is p-doped, and the ion implanted is B or BF2; for PMOS devices, the heavily doped layer is n-doped, and the ion implanted is P or As.
14. The method according to claim 7 in step b), for NMOS devices, the heavily doped layer is p-doped, and the ion implanted is B or BF2; for PMOS devices, the heavily doped layer is n-doped, and the ion implanted is P or As.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

What is claimed is:

1. An apparatus for maintaining a donor organ at a reduced temperature until reperfusion comprising:
a donor organ receiving portion; and
a temperature controlling mechanism, whereby the donor organ is contained in the donor organ receiving portion until reperfusion.
2. An apparatus for maintaining a donor organ at a reduced temperature until the vascular pedicle of the donor organ is connected to the recipient’s blood supply comprising:
a donor organ receiving portion; and
a temperature controlling mechanism, whereby the donor organ is contained in the donor organ receiving portion, with the vascular pedicle protruding from the donor organ receiving portion, and the donor organ is maintained at a reduced temperature until the vascular pedicle is attached to the recipient’s blood supply.
3. The apparatus of claims 1 or 2, wherein the reduced temperature is below 10 C.
4. The apparatus of claims 1 or 2, wherein the reduced temperature is about 4 C.
5. The apparatus of claims 1 or 2, wherein the reduced temperature is a temperature of hypothermic metabolic arrest of the organ.
6. The apparatus of any one of claims 1 through 5, wherein the donor organ receiving portion contacts at least about 70% of the surface area of the donor organ.
7. The apparatus of claim 6, wherein the donor organ receiving portion contacts at least about 80% of the surface area of the donor organ.
8. The apparatus of claim 7, wherein the donor organ receiving portion contacts at least about 90% of the surface area of the donor organ.
9. The apparatus of any one of claims 1 through 8, wherein the donor organ receiving portion is a pliable sleeve or blanket that wraps about the donor organ with the vascular pedicle of the donor organ protruding from the sleeve or blanket.
10. The apparatus of claim 9, further comprising fasteners for maintaining the sleeve or blanket wrapped about the donor organ and allowing for the easy removal of the sleeve or blanket after reperfusion.
11. The apparatus of claim 9, wherein the sleeve or blanket has an inner surface and an outer surface, whereby the donor organ is placed on the inner surface and the sleeve or blanket wraps about the donor organ.
12. The apparatus of any one of claims 1 through 11, further comprising a disposable, removable sterile cover for encasing the donor organ receiving portion.
13. The apparatus of any one of claims 1 through 12, wherein the temperature controlling mechanism comprises an internal pathway in the donor organ receiving portion through which fluid is circulated.
14. An apparatus of any one of claims 1 through 13 further comprising a heating means for heating the donor organ receiving portion.
15. A medical device kit, comprising one or more of the apparatus of any one of claims 1 through 14.
16. The kit of claim 15, wherein the one or more apparatus are packaged in sterile condition.
17. A method for maintaining a donor organ ex vivo at a reduced temperature until reperfusion comprising:
providing a pre-cooled temperature controlled donor organ receiving apparatus;
wrapping the donor organ in the temperature controlled donor organ receiving apparatus while allowing the vascular pedicle of the donor organ to protrude;
maintaining the donor organ at a reduced temperature;
attaching the vascular pedicle to the recipient’s blood vessels; and
removing the organ from the temperature controlled donor organ receiving apparatus.
18. A method for maintaining a donor organ ex vivo at a reduced temperature until reperfusion comprising contacting an apparatus of any one of claims 1 through 14 with a donor organ in the apparatus.
19. A method of claims 17 or 18, wherein the reduced temperature is below 10 C.
20. The method of claims 17 or 18, wherein the reduced temperature is about 4 C.
21. The method of claims 17 or 18, wherein the reduced temperature is a temperature of hypothermic metabolic arrest of the organ.
22. The method of any one of claims 17 through 21, wherein the donor organ receiving portion contacts at least about 70% of the surface area of the donor organ.
23. The method of claim 22, wherein the donor organ receiving portion contacts at least about 80% of the surface area of the donor organ.
24. The method of claim 23, wherein the donor organ receiving portion contacts at least about 90% of the surface area of the donor organ.
25. The method of any one claims 17 through 24, wherein the donor organ receiving portion is a pliable sleeve or blanket that wraps about the donor organ with the vascular pedicle of the donor organ protruding from the sleeve or blanket.
26. The method of claim 25, further comprising maintaining the sleeve or blanket wrapped about the donor organ by fasteners and removing the organ from the sleeve or blanket by unfastening the fasteners.
27. The method of any one of claims 17 through 26, further comprising encasing the donor organ receiving portion with a disposable, removable sterile cover.
28. The method of any one of claims 17 through 27, wherein the organ is a solid organ.
29. The method of any one of claims 17 through 28 wherein the organ is a kidney, liver, lung, heart or pancreas.
30. The method of any one of claims 17 through 28 wherein the organ is a hand, foot, or finger.
31. The method of any one of claims 17 through 30, further comprising heating the donor organ after reperfusion or just prior to reperfusion to assist in returning the donor organ to its functioning metabolic demands.